80 related articles for article (PubMed ID: 8831712)
1. Immunochemical detection of carboxymethylated Apo B-100 in copper-oxidized LDL.
Kato Y; Tokunaga K; Osawa T
Biochem Biophys Res Commun; 1996 Sep; 226(3):923-7. PubMed ID: 8831712
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a specific polyclonal antibody against 13-hydroperoxyoctadecadienoic acid-modified protein: formation of lipid hydroperoxide-modified apoB-100 in oxidized LDL.
Kato Y; Makino Y; Osawa T
J Lipid Res; 1997 Jul; 38(7):1334-46. PubMed ID: 9254060
[TBL] [Abstract][Full Text] [Related]
3. Detection of oxidized phospholipid-protein adducts using anti-15-hydroperoxyeicosatetraenoic acid-modified protein antibody: contribution of esterified fatty acid-protein adduct to oxidative modification of LDL.
Kato Y; Osawa T
Arch Biochem Biophys; 1998 Mar; 351(1):106-14. PubMed ID: 9500842
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody.
Nagai R; Fujiwara Y; Mera K; Yamagata K; Sakashita N; Takeya M
J Immunol Methods; 2008 Mar; 332(1-2):112-20. PubMed ID: 18242632
[TBL] [Abstract][Full Text] [Related]
5. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
Koito W; Araki T; Horiuchi S; Nagai R
J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins.
Yan LJ; Lodge JK; Traber MG; Packer L
Arch Biochem Biophys; 1997 Mar; 339(1):165-71. PubMed ID: 9056246
[TBL] [Abstract][Full Text] [Related]
7. Effect of desialylation on low density lipoproteins: comparative study before and after oxidative stress.
Dousset N; Dousset JC; Taus M; Ferretti G; Curatola G; Soléra ML; Valdiguié P
Biochem Mol Biol Int; 1994 Mar; 32(3):555-63. PubMed ID: 8032323
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions.
Moguilevsky N; Zouaoui Boudjeltia K; Babar S; Delrée P; Legssyer I; Carpentier Y; Vanhaeverbeek M; Ducobu J
Biochem Biophys Res Commun; 2004 Oct; 323(4):1223-8. PubMed ID: 15451427
[TBL] [Abstract][Full Text] [Related]
9. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
Sakata N; Moh A; Takebayashi S
Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of apolipoprotein B-100 thiol depletion during oxidative modification of low-density lipoprotein.
Ferguson E; Singh RJ; Hogg N; Kalyanaraman B
Arch Biochem Biophys; 1997 May; 341(2):287-94. PubMed ID: 9169017
[TBL] [Abstract][Full Text] [Related]
11. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence for apo B-100-mediated copper reduction: studies with purified apo B-100 and detection of tryptophanyl radicals.
Batthyány C; Santos CX; Botti H; Cerveñansky C; Radi R; Augusto O; Rubbo H
Arch Biochem Biophys; 2000 Dec; 384(2):335-40. PubMed ID: 11368321
[TBL] [Abstract][Full Text] [Related]
13. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
[TBL] [Abstract][Full Text] [Related]
14. Development of capture assays for different modifications of human low-density lipoprotein.
Virella G; Derrick MB; Pate V; Chassereau C; Thorpe SR; Lopes-Virella MF
Clin Diagn Lab Immunol; 2005 Jan; 12(1):68-75. PubMed ID: 15642987
[TBL] [Abstract][Full Text] [Related]
15. Effects of oxidation on the structure and stability of human low-density lipoprotein.
Jayaraman S; Gantz DL; Gursky O
Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660
[TBL] [Abstract][Full Text] [Related]
16. Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage.
Kakinuma T; Yasuda T; Nakagawa T; Hiramitsu T; Akiyoshi M; Akagi M; Sawamura T; Nakamura T
Arthritis Rheum; 2004 Nov; 50(11):3495-503. PubMed ID: 15529384
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.
Virella G; Koskinen S; Krings G; Onorato JM; Thorpe SR; Lopes-Virella M
Clin Immunol; 2000 May; 95(2):135-44. PubMed ID: 10779407
[TBL] [Abstract][Full Text] [Related]
18. Generation and initial characterization of a novel polyclonal antibody directed against homocysteine thiolactone-modified low density lipoprotein.
Ferguson E; Parthasarathy S; Joseph J; Kalyanaraman B
J Lipid Res; 1998 Apr; 39(4):925-33. PubMed ID: 9555955
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactivity of apolipoprotein B-100 in oxidatively modified low density lipoprotein.
Valentinova NV; Gu ZW; Yang M; Yanushevskaya EV; Antonov IV; Guyton JR; Smith CV; Gotto AM; Yang CY
Biol Chem Hoppe Seyler; 1994 Oct; 375(10):651-8. PubMed ID: 7534086
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of leaf extract of Zanthoxylum ailanthoides on oxidation of low-density lipoprotein and accumulation of lipid in differentiated THP-1 cells.
Chu CY; Lee HJ; Chu CY; Yin YF; Tseng TH
Food Chem Toxicol; 2009 Jun; 47(6):1265-71. PubMed ID: 19254748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
